1. Home
  2. Ritonavir
  Subject:

Ritonavir   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
HIV  5 times
Hepatitis C virus  4 times
Antiviral drug  4 times
Viral load  3 times
Retrovirus  3 times
Hepatitis C  3 times
Confidence interval  3 times
Cirrhosis  3 times
Ribavirin  2 times
RNA  2 times
Logistic regression  2 times
Enzyme inhibitor  2 times
Efavirenz  2 times
CD4  2 times
Bilirubin  2 times
Zidovudine  1 time
World Health Organization  1 time
Tenofovir disoproxil  1 time
Syndrome  1 time
Statistical power  1 time
Single-nucleotide polymorphism  1 time
Reverse transcriptase  1 time
Regression analysis  1 time
Polyelectrolyte  1 time
Pharmacokinetics  1 time
Odds ratio  1 time
Nucleotide  1 time
Nucleoside  1 time
Natural reservoir  1 time
NS5A  1 time
Metabolite  1 time
Malawi  1 time
Macular degeneration  1 time
Lipid metabolism  1 time
Kaplan–Meier estimator  1 time
Japan  1 time
Itch  1 time
Israel  1 time
Insomnia  1 time
Infrared spectroscopy  1 time
Hemoglobin  1 time
Hemodialysis  1 time
Final Analysis  1 time
Fibrosis  1 time
Fasting  1 time
Drug interaction  1 time
Differential scanning calorimetry  1 time
Diabetes mellitus  1 time
Cytochrome P450  1 time
Complete blood count  1 time
Clinical trial  1 time
Burkina Faso  1 time
Blood plasma  1 time
Biological half-life  1 time
Alanine transaminase  1 time
Adenocarcinoma  1 time
Acid  1 time

Publications tagged with this subject: 12

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

2. Synthesis, Comparison, and Optimization of a Humic Acid-Quat10 Polyelectrolyte Complex by Complexation-Precipitation versus Extrusion-Spheronization

3. Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection

4. Clinical Pharmacokinetics of Dasabuvir

5. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

6. Primary HIV Infection: Clinical Presentation, Testing, and Treatment

7. Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin for Treatment of Hepatitis C Virus Genotype 1: A Systematic Review and Meta-analysis

8. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial

9. Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C

10. Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort

11. Exposure–Safety Response Relationship for Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Data from Five Phase II and Six Phase III Studies

12. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi


Questions?

Drop us a message.